Correlation Between NanoVibronix and Icecure Medical

Can any of the company-specific risk be diversified away by investing in both NanoVibronix and Icecure Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NanoVibronix and Icecure Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NanoVibronix and Icecure Medical, you can compare the effects of market volatilities on NanoVibronix and Icecure Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NanoVibronix with a short position of Icecure Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NanoVibronix and Icecure Medical.

Diversification Opportunities for NanoVibronix and Icecure Medical

0.22

Correlation Coefficient

NanoVibronix  Icecure Medical

Modest diversification

The 3 months correlation between NanoVibronix and Icecure is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding NanoVibronix and Icecure Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icecure Medical and NanoVibronix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NanoVibronix are associated (or correlated) with Icecure Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icecure Medical has no effect on the direction of NanoVibronix i.e., NanoVibronix and Icecure Medical go up and down completely randomly.

Pair Corralation between NanoVibronix and Icecure Medical

Given the investment horizon of 90 days NanoVibronix is expected to under-perform the Icecure Medical. But the stock apears to be less risky and, when comparing its historical volatility, NanoVibronix is 1.07 times less risky than Icecure Medical. The stock trades about -0.01 of its potential returns per unit of risk. The Icecure Medical is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  64.00  in Icecure Medical on September 21, 2024 and sell it today you would earn a total of  50.00  from holding Icecure Medical or generate 78.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

NanoVibronix  vs.  Icecure Medical

NanoVibronix

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NanoVibronix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, NanoVibronix is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Icecure Medical

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Icecure Medical are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Icecure Medical displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NanoVibronix and Icecure Medical

The main advantage of trading using opposite NanoVibronix and Icecure Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NanoVibronix position performs unexpectedly, Icecure Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icecure Medical will offset losses from the drop in Icecure Medical's long position.

The idea behind NanoVibronix and Icecure Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.